ATE374024T1 - Verwendung von 5-methoxytryptamin als kardioprotektives mittel - Google Patents

Verwendung von 5-methoxytryptamin als kardioprotektives mittel

Info

Publication number
ATE374024T1
ATE374024T1 AT04745141T AT04745141T ATE374024T1 AT E374024 T1 ATE374024 T1 AT E374024T1 AT 04745141 T AT04745141 T AT 04745141T AT 04745141 T AT04745141 T AT 04745141T AT E374024 T1 ATE374024 T1 AT E374024T1
Authority
AT
Austria
Prior art keywords
methoxytryptamine
cardioprotective agent
prevention
treatment
tissue damage
Prior art date
Application number
AT04745141T
Other languages
English (en)
Inventor
Rama Mukherjee
Anu T Singh
Kakali Dutta
G C Maikap
Anil Kumar Shukla
Dhiraj Khattar
Anand C Burman
Original Assignee
Dabur Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Res Foundation filed Critical Dabur Res Foundation
Application granted granted Critical
Publication of ATE374024T1 publication Critical patent/ATE374024T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AT04745141T 2003-07-25 2004-07-19 Verwendung von 5-methoxytryptamin als kardioprotektives mittel ATE374024T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/627,398 US20050020666A1 (en) 2003-07-25 2003-07-25 Cardioprotective agents

Publications (1)

Publication Number Publication Date
ATE374024T1 true ATE374024T1 (de) 2007-10-15

Family

ID=34080633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04745141T ATE374024T1 (de) 2003-07-25 2004-07-19 Verwendung von 5-methoxytryptamin als kardioprotektives mittel

Country Status (5)

Country Link
US (2) US20050020666A1 (de)
EP (1) EP1653948B1 (de)
AT (1) ATE374024T1 (de)
DE (1) DE602004009197D1 (de)
WO (1) WO2005009419A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008092084A2 (en) 2007-01-26 2008-07-31 Centocor, Inc. Injectable non-aqueous suspension with high concentration of therapeutic agent
EP2140265B1 (de) * 2007-03-22 2012-10-31 Scandinavian Micro Biodevices A/S Durchflusssystem, durchflussvorrichtung und verfahren zur durchführung eines tests
EP2307141B1 (de) 2008-07-29 2019-02-20 Scandinavian Micro Biodevices ApS Mikrofluidische vorrichtung
US10792331B2 (en) * 2015-09-09 2020-10-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods for reducing cardiotoxicity from chemotherapy by administering humanin analog compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU227537A1 (en) * 1960-09-19 1978-06-15 P G Zherebchenko Medicine
EP0330625B1 (de) * 1988-02-25 1995-12-20 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi Verfahren zur totalen Synthese von einer Indol-Struktur-Verbindungsklasse des Tryptamin-Typs, insbesondere Melatonin- oder N-Acetyl-5-methoxytryptamin mit hoher Reinheit und Löslichkeit, verwendbar in der AIDS-Therapie
US5405863A (en) * 1992-12-01 1995-04-11 Smithkline Beecham Corporation Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds
HUP9800731A3 (en) * 1995-03-06 2000-03-28 Novo Nordisk As Stimulation of meiosis
FR2751539B1 (fr) * 1996-07-25 1998-12-04 Oreal Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
US5885293A (en) * 1997-03-03 1999-03-23 Innovasive Devices, Inc. Apparatus and method for cutting a surface at a repeatable angle
AU5168700A (en) * 1999-05-28 2000-12-18 Synaptic Pharmaceutical Corporation Dna encoding snorf33 receptor
PT1272177E (pt) * 2000-01-05 2007-07-11 Neurim Pharma 1991 Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas.
JP2005524601A (ja) * 2000-09-15 2005-08-18 ザ スクリップス リサーチ インスティテュート 抗体による過酸化水素およびスーパーオキシド生成に関する方法および組成物
WO2002038141A2 (en) * 2000-11-08 2002-05-16 Massachusetts Institute Of Technology Compositions and methods for treatment of mild cognitive impairment
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy

Also Published As

Publication number Publication date
EP1653948B1 (de) 2007-09-26
DE602004009197D1 (de) 2007-11-08
WO2005009419A2 (en) 2005-02-03
WO2005009419A3 (en) 2005-03-24
US20070203248A1 (en) 2007-08-30
EP1653948A2 (de) 2006-05-10
US20050020666A1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE464889T1 (de) Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE552236T1 (de) Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz
NO20091655L (no) Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer
CY1115117T1 (el) Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα
ATE385419T1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
ATE433954T1 (de) Hydroxamate als therapeutische mittel
TW200606162A (en) Pyrazolopyridine derivatives
DE602004004665D1 (en) Acetylenderivate als inhibitoren von histondeacetylase
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
NO20050514L (no) Sammensetning og antiviral aktivitet til substituerte azaindoloksoeddikpiperazinderivater
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE602006020775D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von manie und bipolaren störungen
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
ATE458750T1 (de) Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
ATE374024T1 (de) Verwendung von 5-methoxytryptamin als kardioprotektives mittel
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
ATE556053T1 (de) Piperidinderivate zur behandlung von alzheimer- krankheit
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties